A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)

Clinical trial NCT02000375 · TERMINATED

Trial details

NCT number: NCT02000375
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breastcancer Estrogen Receptor Positive Breast Cancer Estrogen Receptor Negative Neoplasm Progesterone Receptor Positive Tumor Progesterone Receptor Negative Neoplasm Androgen Receptor Gene Overexpression

Start date: 2013-03-01
Primary completion: 2016-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.